Enlivex Ltd Share Price Today: Live Updates & Key Insights

Enlivex Ltd share price today is $1.03, up -5.56%. The stock opened at $1.09 against the previous close of $1.08, with an intraday high of $1.09 and low of $1.02.

Enlivex Ltd Share Price Chart

Enlivex Ltd

us-stock
To Invest in {{usstockname}}
us-stock

Enlivex Ltd Share Price Performance

$1.03 -0.0556(-5.56%) ENLV at 23 Mar 2026 12:53 PM Biotechnology
Lowest Today 1.02
Highest Today 1.09
Today’s Open 1.09
Prev. Close 1.08
52 Week High 2.10
52 Week Low 0.66
Day’s Range: Low 1.02 High 1.09
52-Week Range: Low 0.66 High 2.10
1 day return -
1 Week return -4.67
1 month return -2.85
3 month return +22.36
6 month return -2.85
1 year return +3.84
3 year return -70.34
5 year return -92.04
10 year return -

Enlivex Ltd Institutional Holdings

ARK Israel Innovative Technology ETF 0.26

Renaissance Technologies Corp 0.13

Citizens Financial Group Inc 0.10

Two Sigma Investments LLC 0.08

Morgan Stanley - Brokerage Accounts 0.07

HRT FINANCIAL LLC 0.06

Jane Street Group LLC 0.03

Invesco NASDAQ Future Gen 200 ETF 0.03

XTX Topco Ltd 0.02

Citadel Advisors Llc 0.01

Prosperity Consulting Group, LLC 0.01

Neuberger Berman Group LLC 0.00

SkyView Investment Advisors, LLC 0.00

Wells Fargo & Co 0.00

Fidelity Nasdaq Composite Index 0.00

UBS Group AG 0.00

MCGUIRE CAPITAL ADVISORS INC 0.00

Advisor Group Holdings, Inc. 0.00

Tower Research Capital LLC 0.00

Activest Wealth Management 0.00

Bfsg, LLC 0.00

SRS Capital Advisors Inc 0.00

Steward Partners Investment Advisory, LLC 0.00

Enlivex Ltd Market Status

Strong Buy: 1

Buy: 1

Hold: 0

Sell: 0

Strong Sell: 0

Enlivex Ltd Fundamentals

Market Cap 242.13 M

PB Ratio 13.9868

PE Ratio 0.0

Enterprise Value 227.00 M

Total Assets 27.69 M

Volume 240224

Enlivex Ltd Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:2277000 2.3M, FY19:0 0.0M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:2277000 2.3M, FY19:null 0.0M

Annual Net worth FY23:-27162000 -27.2M, FY22:-42407000 -42.4M, FY21:-9648000 -9.6M, FY20:-13863000 -13.9M, FY19:-10149000 -10.1M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:-81000 -0.1M, Q2/2025:-85000 -0.1M, Q1/2025:-90000 -0.1M, Q3/2024:null 0.0M, Q2/2024:-160000 -0.2M

Quarterly Net worth Q3/2025:-2205000 -2.2M, Q2/2025:-1868000 -1.9M, Q1/2025:-3452000 -3.5M, Q3/2024:-2602000 -2.6M, Q2/2024:-3096000 -3.1M

About Enlivex Ltd & investment objective

Company Information Enlivex Ltd., together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel. Its product pipeline is the Allocetra (ENX-CL-02-002), which is in phase II clinical trial for the treatment of organ dysfunction and failure caused by sepsis; and Allocetra (ENX-CL-05-001), which is in phase I/II clinical trial to treat moderate knee osteoarthritis. The company also develops 0189-22-KMC, which is in phase I/II clinical trial to treat end-stage knee osteoarthritis; 0006-24-KMC, which is in phase I/II clinical trial for the treatment of Basal thumb osteoarthritis; and ENX-CL-06-001 to treat Psoriatic arthritis and is in phase I/II clinical trial. Enlivex Ltd. was formerly known as Enlivex Therapeutics Ltd. and changed its name to Enlivex Ltd. in February 2026. The company was founded in 2005 and is headquartered in Ness Ziona, Israel.

Organisation Biotechnology

Employees 0

Industry Biotechnology

CEO null

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Enlivex Ltd FAQs

What is the share price of Enlivex Ltd today?

The current share price of Enlivex Ltd is $1.03.

Can I buy Enlivex Ltd shares in India?

Yes, Indian investors can buy Enlivex Ltd shares by opening an international trading and demat account with Motilal Oswal.

How to buy Enlivex Ltd shares in India?

You can easily invest in Enlivex Ltd shares from India by:

Can I buy fractional shares of Enlivex Ltd?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Enlivex Ltd?

Enlivex Ltd has a market cap of $242.13 M.

In which sector does Enlivex Ltd belong?

Enlivex Ltd operates in the Biotechnology sector.

What documents are required to invest in Enlivex Ltd stocks?

To invest, you typically need:

What is the PE and PB ratio of Enlivex Ltd?

The PE ratio of Enlivex Ltd is N/A and the PB ratio is 13.99.